Quality of Life in Ovarian Cancer Patients Receiving Chemotherapy
Gynecologic OncologyPublished 1 June 2001
Cherelyn Lakusta, Mark J. Atkinson, John W. Robinson, Jill Nation, Paul Taenzer, Mary Grace Campo
Citations87
SJR quartileQ1
SJR score1.88
SNIP1.39
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The results confirmed the assumption that carboplatin has less of an impact on QoL than cisplatin, and the finding of improvements inQoL over time, for the women with recurrent disease, supports the use of carboplasin as palliative treatment.
Abstract
The EORTC QLQ-C30 can be used to test clinical assumptions and to influence treatment programs of women with ovarian cancer undergoing chemotherapy. The results confirmed the assumption that carboplatin has less of an impact on QoL than cisplatin. Also, the finding of improvements in QoL over time, for the women with recurrent disease, supports the use of carboplatin as palliative treatment. The differences observed in QoL between survivors and nonsurvivors 12 months after starting treatment may help identify high-risk patients for closer monitoring. Brief, structured QoL assessments before clinic appointments may be useful for improving the overall care of ovarian cancer patients.
Keywords
Medicine
JNCI Journal of the National Cancer InstituteThe European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
15,964 Citations1993N.K. Aaronson, Sam H. Ahmedzai +17 more
The reliability and validity of the EORTC QLQ-C30 questionnaire were highly consistent across the three language-cultural groups studied: patients from English-speaking countries, Northern Europe, and Southern Europe.
Journal of Clinical OncologyReview of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
697 Citations1999Ronald S. Go, Alex A. Adjei
Carboplatin does not possess equivalent activity to cisplatin in all platinum-sensitive tumors, and its role in limited-stage small-cell lung cancer needs to be investigated further.
Quality of Life ResearchPsychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer
418 Citations1994David Osoba, Benny Zee +4 more
The QLQ-C30 is responsive to the effects of chemotherapy and of metastatic disease, and patients with breast and ovarian cancer had better physical, role and social functioning, and less fatigue and pain than patients with ovarian cancer.
Effect of Cancer on Quality of Life
238 Citations2021David Osoba
Quality of Life in the Treatment Process in Pediatric Oncology, Quality-of-Life Research in the European Palliative Care Setting, and Uses (and Some Possible Abuses) of Quality- of-Life Measures.
Social Science & MedicineA study of quality of life in cancer patients receiving palliative chemotherapy
189 Citations1992Sheila Payne
Quality of life broadens the criteria by which cancer treatments are evaluated, to include the experience of the patient, to understand the impact of cancer upon the patient.
The EORTC Core Quality-of-Life Questionnaire: Interim Results of an International Field Study *
158 Citations2021Neil K. Aaronson, Sam H. Ahmedzai +16 more
The juice is homogenized by applying vigorous and repeated shearing action to cause extensive damage to the fruit cells and thereby increase the consistency of the juice.
Gynecologic OncologyQuality of Life of Women with Ovarian Cancer
153 Citations1995Alice B. Kornblith, Howard T. Thaler +7 more
The need for an improved and more frequent assessment of ovarian cancer patients' psychological status, particularly as physical functioning declines, is suggested to improve early detection and referral to treatment of those suffering from psychiatric sequelae of cancer.
Surgical OncologyCancer of the Ovary
142 Citations1989Francesco Di Re, Rosanna Fontanelli
Ov ovarian cancer has shown a slight but gradual increase in incidence and at present it makes up 5% of all female malignancies and 20% of female genital tumours (Waterhouse et al. 1982).
Nutrition and CancerThe interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary
116 Citations1993Lars Ovesen, Jens Hannibal +1 more
It is shown that many ambulatory cancer patients do not eat enough to maintain weight and that even a moderate weight loss is associated with psychological distress and lower quality of life.
PubMedComputerized quality-of-life screening in an oncology clinic.
100 Citations1997Paul Taenzer, Michael Speca +5 more
The results of these studies indicate that computerized quality-of-life screening is feasible and may provide reliable data for research and quality assurance studies and staff evaluations suggest that the written report may provide clinic staff members with a tool for identifying quality- of-life concerns in which individual patients are experiencing difficulty.
Annals of OncologyFirst line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?
85 Citations1999Andreas du Bois, J.P. Neijt +1 more
Supportive Care in CancerQuality of life in patients with ovarian cancer: Current state of research
59 Citations1996Ali Montazeri, J. McEwen +1 more
It appears that debulking surgery followed by platinum-based chemotherapy could improve both quality of life and survival, and a large carefully planned international study is required.
CancerQuality of life in patients with gynecologic cancer
58 Citations1987Cheryl F. McCartney, David B. Larson
Reliable QL measures are useful for rating the QL costs of cancer itself, for rating existing cancer treatments and therapies under clinical investigation, and for evaluating the effectiveness of interventions to improve or prevent deterioration in QL status.
Current Problems in CancerEarly ovarian cancer: A review of its genetic and biologic factors, detection, and treatment
13 Citations1996Matthew Boente, T C Hamilton +6 more
It is hoped that clinicians will continue to encourage patients to participate in randomized clinical trials so that optimal therapy for early ovarian cancer can be established.
PubMed[Carboplatin in the treatment of ovarian carcinoma; as effective and less toxic in comparison with cisplatin].
2 Citations1991P.H.B. Willemse, P H Blom van Assendelft +4 more
Quality of life, measured by TWIST, is significantly better during CC, and carboplatin should replace cisplatin in treating patients with advanced ovarian cancer.